Erratum: Haplotype Counting by Next-Generation Sequencing for Ultrasensitive Human DNA Detection (The Journal of Molecular Diagnostics (2014) 16 (495-503) DOI: 10.1016/j.jmoldx.2014.04.003);Haplotype counting by next-generation sequencing for ultrasensitive human DNA detection

Journal of Molecular Diagnostics

Volumn 16, Issue 5, 2014, Pages 495-503

  Debeljak, Marija ^a   Freed, Donald N ^a   Welch, Jane A ^b   Haley, Lisa ^a   Beierl, Katie ^a   Iglehart, Brian S ^a   Pallavajjala, Aparna ^a   Gocke, Christopher D ^a   Leffell, Mary S ^a   Lin, Ming Tseh ^a   Pevsner, Jonathan ^a   Wheelan, Sarah J ^b   Eshleman, James R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BONE MARROW ENGRAFTMENT; BONE MARROW TRANSPLANTATION; CAPILLARY ELECTROPHORESIS; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DONOR; GENE AMPLIFICATION; GENE LOCUS; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN GENOME; LIMIT OF DETECTION; MICROCHIMERISM; PATIENT SAFETY; RELAPSE; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; BONE MARROW CELL; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; TUMOR CELL LINE;

DNA; HLA A ANTIGEN;

ALLELES; BONE MARROW CELLS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DNA; GENETIC TESTING; GENOME, HUMAN; HAPLOTYPES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HLA-A ANTIGENS; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84906248336     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.09.001     Document Type: Erratum

References (40)

1. S. Slavin, A. Nagler, E. Naparstek, Y. Kapelushnik, M. Aker, G. Cividalli, G. Varadi, M. Kirschbaum, A. Ackerstein, S. Samuel, A. Amar, C. Brautbar, O. Ben-Tal, A. Eldor, and R. Or Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 1998 756 763
2. I.F. Khouri, R.M. Saliba, S.A. Giralt, M.S. Lee, G.J. Okoroji, F.B. Hagemeister, M. Korbling, A. Younes, C. Ippoliti, J.L. Gajewski, P. McLaughlin, P. Anderlini, M.L. Donato, F.F. Cabanillas, and R.E. Champlin Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality Blood 98 2001 3595 3599
3. R.A. Brodsky, L. Luznik, J. Bolanos-Meade, M.S. Leffell, R.J. Jones, and E.J. Fuchs Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases Bone Marrow Transplant 42 2008 523 527
4. J. Bolanos-Meade, E.J. Fuchs, L. Luznik, S.M. Lanzkron, C.J. Gamper, R.J. Jones, and R.A. Brodsky HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease Blood 120 2012 4285 4291
5. A.J. Jeffreys, V. Wilson, and S.L. Thein Individual-specific "fingerprints" of human DNA Nature 316 1985 76 79
6. S.J. Scharf, A.G. Smith, J.A. Hansen, C. McFarland, and H.A. Erlich Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers Blood 85 1995 1954 1963
7. C. Thiede, M. Florek, M. Bornhauser, M. Ritter, B. Mohr, C. Brendel, G. Ehninger, and A. Neubauer Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection Bone Marrow Transplant 23 1999 1055 1060
8. S.A. Schichman, P. Suess, A.M. Vertino, and P.S. Gray Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment Bone Marrow Transplant 29 2002 243 248
9. K.A. Mills, D. Even, and J.C. Murray Tetranucleotide repeat polymorphism at the human alpha fibrinogen locus (FGA) Hum Mol Genet 1 1992 779
10. N.E. Huang, J. Schumm, and B. Budowle Chinese population data on three tetrameric short tandem repeat loci-HUMTHO1, TPOX, and CSF1PO-derived using multiplex PCR and manual typing Forensic Sci Int 71 1995 131 136
11. D.H. Oliver, R.E. Thompson, C.A. Griffin, and J.R. Eshleman Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis J Mol Diagn 2 2000 202 208
12. E.P. Hochberg, D.B. Miklos, D. Neuberg, D.A. Eichner, S.F. McLaughlin, A. Mattes-Ritz, E.P. Alyea, J.H. Antin, R.J. Soiffer, and J. Ritz A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation Blood 101 2003 363 369
13. E. Gineikiene, M. Stoskus, and L. Griskevicius Single nucleotide polymorphism-based system improves the applicability of quantitative PCR for chimerism monitoring J Mol Diagn 11 2009 66 74
14. L.M. Bragg, G. Stone, M.K. Butler, P. Hugenholtz, and G.W. Tyson Shining a light on dark sequencing: characterising errors in Ion Torrent PGM data PLoS Comput Biol 9 2013 e1003031
15. J.M. Rothberg, W. Hinz, T.M. Rearick, J. Schultz, W. Mileski, and M. Davey et al. An integrated semiconductor device enabling non-optical genome sequencing Nature 475 2011 348 352
16. B. Merriman Ion Torrent R&D Team J.M. Rothberg Progress in ion torrent semiconductor chip based sequencing Electrophoresis 33 2012 3397 3417
17. B.N. Howie, P. Donnelly, and J. Marchini A flexible and accurate genotype imputation method for the next generation of genome-wide association studies PLoS Genet 5 2009 e1000529
18. O. Delaneau, J.F. Zagury, and J. Marchini Improved whole-chromosome phasing for disease and population genetic studies Nat Methods 10 2013 5 6
19. C. Gabriel, D. Furst, I. Fae, S. Wenda, C. Zollikofer, J. Mytilineos, and G.F. Fischer HLA typing by next-generation sequencing: getting closer to reality Tissue Antigens 83 2014 65 75
20. D. De Santis, D. Dinauer, J. Duke, H.A. Erlich, C.L. Holcomb, C. Lind, K. Mackiewicz, D. Monos, A. Moudgil, P. Norman, P. Parham, A. Sasson, and R.J. Allcock 16(th) IHIW: review of HLA typing by NGS Int J Immunogenet 40 2013 72 76
21. L. Clarke, X. Zheng-Bradley, R. Smith, E. Kulesha, C. Xiao, I. Toneva, B. Vaughan, D. Preuss, R. Leinonen, M. Shumway, S. Sherry, P. Flicek 1000 Genomes Project Consortium The 1000 Genomes Project: data management and community access Nat Methods 9 2012 459 462
22. J. Esteve, L. Escoda, G. Martin, V. Rubio, J. Díaz-Mediavilla, M. González, C. Rivas, C. Alvarez, J.D. Gonzalez San Miguel, S. Brunet, J.F. Tomás, M. Tormo, M.J. Sayas, P. Sanchez Godoy, D. Colomer, P. Bolufer, M.A. Sanz Spanish Cooperative Group PETHEMA Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention Leukemia 21 2007 446 452
23. E. Chendamarai, P. Balasubramanian, B. George, A. Viswabandya, A. Abraham, R. Ahmed, A.A. Alex, S. Ganesan, K.M. Lakshmi, U. Sitaram, S.C. Nair, M. Chandy, N.B. Janet, V.M. Srivastava, A. Srivastava, and V. Mathews Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy Blood 119 2012 3413 3419
24. L. Vago, S.K. Perna, M. Zanussi, B. Mazzi, C. Barlassina, M.T. Stanghellini, N.F. Perrelli, C. Cosentino, F. Torri, A. Angius, B. Forno, M. Casucci, M. Bernardi, J. Peccatori, C. Corti, A. Bondanza, M. Ferrari, S. Rossini, M.G. Roncarolo, C. Bordignon, C. Bonini, F. Ciceri, and K. Fleischhauer Loss of mismatched HLA in leukemia after stem-cell transplantation N Engl J Med 361 2009 478 488
25. I.B. Villalobos, Y. Takahashi, Y. Akatsuka, H. Muramatsu, N. Nishio, A. Hama, H. Yagasaki, H. Saji, M. Kato, S. Ogawa, and S. Kojima Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation Blood 115 2010 3158 3161
26. T.E. Starzl, A.J. Demetris, M. Trucco, N. Murase, C. Ricordi, S. Ildstad, H. Ramos, S. Todo, A. Tzakis, J.J. Fung, M. Nalesnik, A. Zeevi, W.A. Rudert, and M. Kocova Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance Hepatology 17 1993 1127 1152
27. R.D. Foster, L. Fan, M. Neipp, C. Kaufman, T. McCalmont, N. Ascher, S. Ildstad, J.P. Anthony, and M. Niepp Donor-specific tolerance induction in composite tissue allografts Am J Surg 176 1998 418 421
28. R.D. Foster, N.L. Ascher, T.H. McCalmont, M. Neipp, J.P. Anthony, and S.J. Mathes Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers Transplantation 72 2001 791 797
29. S. Schneeberger, V.S. Gorantla, G. Brandacher, A. Zeevi, A.J. Demetris, J.G. Lunz, D.M. Metes, A.D. Donnenberg, J.T. Shores, A.F. Dimartini, J.E. Kiss, J.E. Imbriglia, K. Azari, R.J. Goitz, E.K. Manders, V.T. Nguyen, D.S. Cooney, G.S. Wachtman, J.D. Keith, D.R. Fletcher, C. Macedo, R. Planinsic, J.E. Losee, R. Shapiro, T.E. Starzl, and W.P. Lee Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression Ann Surg 257 2013 345 351
30. D.W. Bianchi, G.K. Zickwolf, G.J. Weil, S. Sylvester, and M.A. DeMaria Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum Proc Natl Acad Sci U S A 93 1996 705 708
31. V. Cirello, M. Perrino, C. Colombo, M. Muzza, M. Filopanti, L. Vicentini, P. Beck-Peccoz, and L. Fugazzola Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissues Int J Cancer 126 2010 2874 2878
32. W.F. Chan, C. Gurnot, T.J. Montine, J.A. Sonnen, K.A. Guthrie, and J.L. Nelson Male microchimerism in the human female brain PLoS One 7 2012 e45592
33. F. Quaini, K. Urbanek, A.P. Beltrami, N. Finato, C.A. Beltrami, B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa Chimerism of the transplanted heart N Engl J Med 346 2002 5 15
34. E. Hocht-Zeisberg, H. Kahnert, K. Guan, G. Wulf, B. Hemmerlein, T. Schlott, G. Tenderich, R. Korfer, U. Raute-Kreinsen, and G. Hasenfuss Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation Eur Heart J 25 2004 749 758
35. B. Nurit, G. Anat, S. Michal, F. Lilach, and F. Maya Evaluating the prevalence of DNA mixtures found in fingernail samples from victims and suspects in homicide cases Forensic Sci Int Genet 5 2011 532 537
36. C. Schmitt, and M. Benecke Five cases of forensic short tandem repeat DNA typing Electrophoresis 18 1997 690 694
37. A.J. Pakstis, W.C. Speed, R. Fang, F.C. Hyland, M.R. Furtado, J.R. Kidd, and K.K. Kidd SNPs for a universal individual identification panel Hum Genet 127 2010 315 324
38. W.H. Dzik, H. Corwin, L.T. Goodnough, M. Higgins, H. Kaplan, M. Murphy, P. Ness, I.A. Shulman, and R. Yomtovian Patient safety and blood transfusion: new solutions Transfus Med Rev 17 2003 169 180
39. S.C. Seiden, and P. Barach Wrong-side/wrong-site, wrong-procedure, and wrong-patient adverse events: are they preventable? Arch Surg 141 2006 931 939
40. I. De Vlaminck, H.A. Valantine, T.M. Snyder, C. Strehl, G. Cohen, H. Luikart, N.F. Neff, J. Okamoto, D. Bernstein, D. Weisshaar, S.R. Quake, and K.K. Khush Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection Sci Transl Med 6 2014 241ra77